Fundraising FoxQiming Venture Partners USA — Full Portfolio
9 tracked investments · listed companies and verified rows first
Jasper Therapeutics develops briquilimab, a targeted anti-KIT monoclonal antibody designed to deplete mast cells for treating chronic immunological and inflammatory diseases.
BiotechHealthtechRedwood City, US
Judith Shizuru(Director)Herb Cross(Executive Officer)inJeet Mahal(Executive Officer, Director)inPatrick Crutcher(Director)Svetlana Lucas(Director)Wenru Song(Executive Officer)
Co-investorsAvego BioScience CapitalTSVCAbingworthIkarian Capital
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.
BiotechHealthtechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in
BoardJean-Francois Formela(Director)in
Co-investorsAtlas VentureMC Healthcare VenturesNew Enterprise Associates (NEA)AlexandriaRock Springs CapitalTaiwania Capital+1 more
Umoja Biopharma develops in vivo CAR T cell cancer therapies using its VivoVec platform, which generates chimeric antigen receptor T cells directly inside a patient's body rather than through the traditional ex vivo process.
BiotechHealthtechSeattle, US
Andrew M. Scharenberg(Executive Officer, Director)Philip S. Low(Director)
BoardIrena Melnikova(Executive Officer)Anna French(Director)Robert Glassman(Director)John Hamer(Director)in
Co-investorsMPM BioImpactDCVC BioSoftBank GroupK2 HealthVenturesSoftBank Vision FundDCVC (Data Collective)
BiotechNewton, US
Katharine Yen(Executive Officer, Director)Kate Yen(Founder)inChristopher Guiffre(Executive Officer)
BoardAlon Lazarus(Director)Anna French(Director)inAlexandra Cantley(Director)in
Co-investorsDCVC (Data Collective)Apollo Health VenturesDCVC BioPolaris Partners
Boulder provides medication-assisted treatment for addiction through licensed specialists who prescribe buprenorphine, supported by dedicated care teams offering medical care, peer recovery coaching, and care coordination accessible via a digital platform.
Digital HealthHealthtechMental HealthBoulder, US
Stephanie Papes(Cofounder)
Co-investorsAdvance Venture PartnersAlumni VenturesFirst Round CapitalGreycroftLaerdal Million Lives FundTusk Venture Partners+3 more
Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsSlater Technology FundAccess IndustriesAtlas VentureClal Biotechnology IndustriesCowen Healthcare InvestmentsQiming Venture Partners
Dualitas Therapeutics develops bispecific antibody therapies that pair a proprietary proximity engager arm with an antibody against a therapeutic target, using its DualScreen discovery engine to identify synergistic target combinations.
BiotechDeep TechSouth San Francisco, US
Greg Lazar, Ph.D.(Co-Founder and Chief Scientific Officer)Forbes Huang(Co-Founder, Chief Operating Officer & Chief Business Officer)inGreg Lazar(Co-Founder & Chief Scientific Officer)inRichard Murray(Executive Officer, Director)Karim Dabbagh(Chief Executive Officer, Board Member)inKarim Dabbagh, Ph.D.(Chief Executive Officer, Board Member)in
Co-investorsQiming Venture PartnersSV Health InvestorsVersant VenturesAlexandriaDementia Discovery FundQiming Healthcare
Fuze Health operates a unified digital healthcare platform spanning digital pharmacy (FuzeRx), clinical services such as diagnostics, screening and genetics (Fuze Services), and data and technology tools (Fuze Technologies).
AI & Machine LearningDigital HealthHealthtechSaaS
Co-investorsFJ LabsHLM Investment PartnersIllumina VenturesK2 HealthVenturesOlive Tree CapitalSoftBank Vision Fund+2 more
Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.
BiotechSouth San Francisco, US
John F. Fowler(Executive Officer, Director)inChristopher J. Kirk(Executive Officer, Director)
BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)
Co-investorsBay City CapitalChiesi VenturesPappas CapitalSolasta VenturesCowen Healthcare InvestmentsEcoR1 Capital+1 more
MyHealthTeam builds social networks for people diagnosed with chronic health conditions, connecting patients so they can share experiences and manage their health.
Digital HealthHealthtechSocialSan Francisco, US
Eric Peacock(Co-Founder and CEO)inMary Ray(Co-Founder and COO)inElizabeth Luce(EVP Partnerships and Partner Operations)inTomas Melian(SVP Marketing)inDavid Wygant(SVP Product)inDante Gaudio(EVP of Community)in
Co-investors500 GlobalEvolution VC PartnersSand Hill AngelsThe Westly GroupTSVCAdams Street Partners+2 more
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to restore the function of polycystin 1 and 2 proteins in autosomal dominant polycystic kidney disease (ADPKD).
BiotechHealthtechBerkeley, US
Jeremy Reiter(Scientific Co-Founder)Markus Delling(Scientific Co-Founder)Thomas Gustafson(Executive Officer)inEmily Conley(Executive Officer, Director)in
BoardEvan Caplan(Director)inCharlotte McKee(Director)
Co-investors5AM VenturesOrbiMedAtlas Venture
Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareAlexandria, US
Adam Branch(Executive Officer, Director, Promoter)in
BoardHarrison Touati(Director)Jon Galitzer(Director)
Co-investorsKoch Disruptive TechnologiesLionBirdMitsui Global InvestmentAlleyCorpGaingelsTiger Global Management+1 more
__Twitter.png)
Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.
AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US
Dr. Ittai DayaninIttai Dayan(Dr.)inYuval Baror(Founder)inChristopher Laws(Executive Officer)
BoardEdward Michael(Director)inIvneet Bhullar(Director)in
Co-investorsAlleyCorpE12 Venture Capital, LlcFusionLionBirdMitsui Global InvestmentAlley Robotics Ventures+2 more
Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye.
BiotechDigital HealthHealthtechLongevityMedical DevicesWarren, US
HENRIC BJARKE(Chief Executive Officer)in
Co-investorsAdBio partnersF-Prime CapitalSofinnova Partners
WindMIL Therapeutics is a clinical-stage biotechnology company developing cell-based immuno-oncology therapies using marrow-infiltrating lymphocytes (MILs), T cells extracted from a cancer patient's bone marrow that are activated and expanded before being returned to the patient.
BiotechMedical DevicesPrinceton, US
Ivan Borrello(Founder)Kimberly Noonan(Founder)in
BoardBrian Halak(Executive Officer, Director)
Co-investorsQiming Healthcare
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Amphivena TherapeuticsArmo BiosciencesCardialenEmpiricoevermoreIcosavaxMadaketSatellosStellular BioTalaris TherapeuticsTwine HealthUmojaZappRx
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.